Do cancer patients undergoing surgery for a non-neoplastic related fragility hip fracture have worse outcomes? A retrospective study.
Tal Frenkel RutenbergMaria VitenbergEfrat DaglanJoseph P CostelloShai ShemeshPublished in: Archives of orthopaedic and trauma surgery (2021)
Patients with a history of malignancy in the 5-years prior to a non-neoplastic FHF, showed similar mortality and complications rates during admission but increased 1 year mortality rate when compared to patients without cancer undergoing surgical treatment of a non-neoplastic proximal femoral fracture.
Keyphrases
- hip fracture
- papillary thyroid
- patients undergoing
- end stage renal disease
- risk factors
- squamous cell
- cardiovascular events
- ejection fraction
- newly diagnosed
- emergency department
- chronic kidney disease
- minimally invasive
- lymph node metastasis
- prognostic factors
- metabolic syndrome
- coronary artery disease
- cardiovascular disease
- adipose tissue
- squamous cell carcinoma
- skeletal muscle
- patient reported
- insulin resistance
- surgical site infection
- weight loss